{
  "trial_id": "NCT03681418",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "newly diagnosed patients with operable breast cancer regardless of whether lymph nodes are suspicious or not.",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "candidate for tumor resection and agrees to do so prior to chemotherapy",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who had previously undergone axillary surgery.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients with metastatic disease and not planned for axillary surgery.",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patients with a preoperative diagnosis of a benign lesion or ductal carcinoma in situ.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients with severe uncorrectable bleeding diathesis.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients refused to sign consent.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT03681418",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}